Intellia Therapeutics Names Laura Sepp-Lorenzino, Ph.D., Chief Scientific Officer
Go back to Intellia Therapeutics Names Laura Sepp-Lorenzino, Ph.D., Chief Scientific Officer| (NASDAQ: NTLA) | Delayed: 13.05 -0.46 (3.4%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $13.51 | 52 Week High | $30.40 | |||
| Open | $13.38 | 52 Week Low | $11.86 | |||
| Day High | $13.50 | P/E | N/A | |||
| Day Low | $12.98 | EPS | $0.00 | |||
| Volume | 1,263,609 | |||||

